Clinical Trials
4 trialsNCT02465060 2026-06-03
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT01831726 2017-03-20
SIGNATURE
Novartis
Phase 2 Completed
NCT02002689 2016-05-02
SIGNATURE
Novartis
Phase 2 Terminated
NCT00962494 2013-02-07
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Stanford University
Phase 2 Completed